Teresa A. Phillips

Finger motion required for Auslan: A biomechanical analysis

David J. Graham, Luke McCarron, Teresa A. Phillips, Brahman Sivakumar

BACKGROUND: Australian Sign Language (Auslan) relies heavily on precise finger movements, alongside wrist, forearm, and elbow coordination. Prior studies have examined upper limb biomechanics in Auslan communication but have not quantified the specific range of motion (ROM) required of the fingers. PURPOSE: …

au (code pays fourni par la source)

Range of motion required for Auslan: a biomechanical analysis

David J. Graham, Luke McCarron, Teresa A. Phillips, Brahman Sivakumar

BACKGROUND: Auslan is used by the Australian deaf community and relies heavily on hand, wrist, and elbow movement. Upper limb injury or dysfunction may require surgical intervention to alleviate pain and provide a stable skeleton for function, leading to partial or complete …

au (code pays fourni par la source)

Abstract 3030: Effect of 6 months of bazedoxifene and conjugated estrogen on measures of insulin resistance in postmenopausal women at increased risk for breast cancer

Carol J. Fabian, Erin D. Giles, Katherine L. Cook, Kandy R. Powers et autres

Abstract Background: Bazedoxifene 20 mg (BZA) + Conjugated estrogen 0.45 mg (CE) as Duavee™ is FDA approved for treatment of hot-flashes and prevention of osteoporosis. We are investigating 6 months of BZA + CE vs wait list control in a multisite Phase …

us (code pays fourni par la source)

Data from Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo

Carol J. Fabian, Christie A. Befort, Teresa A. Phillips, Jennifer L. Nydegger et autres

Abstract The inflammation-resolving and insulin-sensitizing properties of eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids have potential to augment effects of weight loss on breast cancer risk. In a feasibility study, 46 peri/postmenopausal women at increased risk for breast cancer with a body …

us (code pays fourni par la source)

Data from Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer

Carol J. Fabian, Seema A. Khan, Judy E. Garber, William C. Dooley et autres

Abstract We conducted a multiinstitutional, placebo-controlled phase IIB trial of the lignan secoisolariciresinol diglucoside (SDG) found in flaxseed. Benign breast tissue was acquired by random periareolar fine needle aspiration (RPFNA) from premenopausal women at increased risk for breast cancer. Those with hyperplasia …

Supplementary Figures and Tables from Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer

Carol J. Fabian, Seema A. Khan, Judy E. Garber, William C. Dooley et autres

Supplementary Figures and Tables

Data from Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo

Carol J. Fabian, Christie A. Befort, Teresa A. Phillips, Jennifer L. Nydegger et autres

Abstract The inflammation-resolving and insulin-sensitizing properties of eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids have potential to augment effects of weight loss on breast cancer risk. In a feasibility study, 46 peri/postmenopausal women at increased risk for breast cancer with a body …

us (code pays fourni par la source)

Supplementary Tables 1-7 from Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo

Carol J. Fabian, Christie A. Befort, Teresa A. Phillips, Jennifer L. Nydegger et autres

Supplemental Table 1: Specimen collection and assay methods details. Supplemental Table 2 Adverse Events Supplemental Table 3. Value and changes in ratio of (DHA+EPA)/AA in erythrocyte phospholipids. Supplemental Table 4. Median relative difference (percent) between baseline and 12 months for 19 serum …

Supplementary Tables 1-7 from Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo

Carol J. Fabian, Christie A. Befort, Teresa A. Phillips, Jennifer L. Nydegger et autres

Supplemental Table 1: Specimen collection and assay methods details. Supplemental Table 2 Adverse Events Supplemental Table 3. Value and changes in ratio of (DHA+EPA)/AA in erythrocyte phospholipids. Supplemental Table 4. Median relative difference (percent) between baseline and 12 months for 19 serum …

Supplementary Figures and Tables from Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer

Carol J. Fabian, Seema A. Khan, Judy E. Garber, William C. Dooley et autres

Supplementary Figures and Tables

Data from Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer

Carol J. Fabian, Seema A. Khan, Judy E. Garber, William C. Dooley et autres

Abstract We conducted a multiinstitutional, placebo-controlled phase IIB trial of the lignan secoisolariciresinol diglucoside (SDG) found in flaxseed. Benign breast tissue was acquired by random periareolar fine needle aspiration (RPFNA) from premenopausal women at increased risk for breast cancer. Those with hyperplasia …

Supplemental Files from Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women

Carol J. Fabian, Bruce F. Kimler, Teresa A. Phillips, Jennifer L. Nydegger et autres

Supplemental Figure 1: CONSORT diagram for flow of potential and actual subjects enrolled on study. Supplementary Table 1. Demographic and risk information at baseline. Supplementary Table 2. Change in anthropomorphic variables. Supplementary Table 3: Changes in levels of cytokines and adipokines in …